Member Info for NanoCapInvestor

𝐆𝐫𝐞𝐚𝐭 𝐑𝐍𝐒 𝐭𝐡𝐢𝐬 𝐦𝐨𝐫𝐧𝐢𝐧𝐠!

We are literally weeks away from the maiden drill program at Lander West.

All regulatory approvals are secured.

This is happening.

More importantly, the NT Government doesn’t hand out 𝐀𝐔$𝟏𝟎𝟎,𝟎𝟎𝟎 for fun.

Round 19 is competitive. The Minister for Mining and Energy personally announced this.

FDR was selected because the technical quality and prospectivity of Lander West stood out. That’s independent, non-dilutive validation from one of Australia’s most respected institutions.

Read that again → 𝐭𝐡𝐞 𝐍𝐓𝐆𝐒 𝐢𝐬 𝐞𝐧𝐝𝐨𝐫𝐬𝐢𝐧𝐠 𝐭𝐡𝐞𝐢𝐫 𝐭𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠.

Remember, most of the prospective geology at Lander West has never been tested below 50m. Previous drilling chased other commodities. The Stafford Gold Trend runs right through it. FDR has systematically integrated modern geophysics with historical data, and they’ve defined multiple concealed gold targets.

𝐓𝐡𝐞 𝐏𝐡𝐚𝐬𝐞 𝐈 𝐩𝐫𝐨𝐠𝐫𝐚𝐦 (𝟐,𝟎𝟎𝟎-𝟑,𝟎𝟎𝟎𝐦 𝐑𝐂) 𝐢𝐬 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐦𝐞𝐚𝐧𝐢𝐧𝐠𝐟𝐮𝐥 𝐭𝐞𝐬𝐭 𝐚𝐭 𝐝𝐞𝐩𝐭𝐡. 𝐓𝐡𝐚𝐭’𝐬 𝐚 𝐠𝐞𝐧𝐮𝐢𝐧𝐞 𝐛𝐥𝐮𝐞-𝐬𝐤𝐲 𝐜𝐚𝐭𝐚𝐥𝐲𝐬𝐭.

Thus, for a UK-listed, Australia-focused explorer with a fully-funded, drill-ready gold target, government-backed, in a Tier-1 jurisdiction (NT), about to spin the bit in 15 working days, the market cap is nonsensical.

𝐄𝐢𝐭𝐡𝐞𝐫 𝐲𝐨𝐮 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐭𝐡𝐞 𝐍𝐓 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐠𝐨𝐭 𝐢𝐭 𝐰𝐫𝐨𝐧𝐠 (𝐮𝐧𝐥𝐢𝐤𝐞𝐥𝐲), 𝐨𝐫 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐡𝐚𝐬𝐧’𝐭 𝐰𝐚𝐤𝐞𝐧 𝐮𝐩 𝐲𝐞𝐭.

The risk-reward here is incredible.

ATB

.

OldWiseBull007, I couldn't agree more.

And today's 6% dip on barely any volume doesn't trouble me in the slightest. That's exactly the kind of noise you expect in a £4m market cap stock where a known seller has been cleaning out the last crumbs of a position. The overhang is now effectively gone; the register is tightening.

The real story is the drill bit.

FDR is fully-funded, the targets are high-conviction, the contractor is already working next door, and the geological model points to a system that could comfortably run to 1.5–3 million ounces.

At 3.05p, you're paying a little over £4m for a free hit at a district-scale gold discovery in a Tier-1 jurisdiction. That's not a valuation, that's an option premium.

Quiet boards are where serious money is made.

By the time there are 100 posts a day and a 300% move is already in the price, the easy gains will be long gone. We're in the calm before the catalysts. Enjoy it. It won't last.

ATB

.

If Itech hits a meaningful sulphide zone, the spotlight on the entire trend, and on FDR’s fully funded Phase I programme, will intensify overnight.

Two junior explorers drilling simultaneously on adjacent tenements, chasing a district-scale gold system that has never been systematically explored at depth: it’s the kind of scenario that gets pulses racing among resource investors and can create a rising tide that lifts both boats.

And things are moving apace.

TMAE, the Alice Springs-based earthworks contractor, has already began cutting access tracks and drill pads.

GeoDrill Australia, already operating on Itech’s ground, will mobilise the RC rig with minimal downtime.

Environmental permits are signed, land access agreements are in place, and the bank account is topped-up.

𝐅𝐃𝐑 𝐢𝐬 𝐝𝐞-𝐫𝐢𝐬𝐤𝐞𝐝 𝐚𝐧𝐝 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐝𝐫𝐢𝐥𝐥.

For the private investor, the narrative is brutally simple; A tightly held AIM explorer, backed by real science, is about to drill a high-conviction gold target that could define a new district. The shares trade at 2.85p, giving a market cap of just under £4M.

The protracted seller that has lingered over the stock for weeks is now down to its last few million shares and may well have walked away for good → leaving a clean register and a fully-funded drill programme ahead.

The company is fully funded, so there is no imminent dilution. The neighbours are drilling concurrently, which means a steady flow of news and a growing wave of district recognition.

And the geological model points towards a prize that could be measured in millions of ounces.

𝐁𝐎𝐓𝐓𝐎𝐌 𝐋𝐈𝐍𝐄

✅ The kit is mobilising.

✅ The ground is prospective.

✅ The neighbours are drilling.

✅ The geophysics is compelling.

✅ The overhang has pretty much cleared.

✅ And the stock is priced as if nothing is about to happen.

Thus, if you’re looking for an asymmetric exploration bet with the potential to deliver a life-changing return, you might want to take a long, hard look at FDR at 2.85p → before the drill bit turns.

.

The integrated geophysical interpretation completed earlier this year revealed a mineralised corridor stretching over 3km at Lander West, with multiple high-order chargeability and resistivity anomalies sitting directly beneath a coherent gold-in-soil footprint.

That footprint peaks at over 100ppb Au and sits exactly on the intersection of the deep-crustal Stafford Fault and a set of oblique cross-structures → 𝐭𝐡𝐞 𝐬𝐚𝐦𝐞 𝐚𝐫𝐜𝐡𝐢𝐭𝐞𝐜𝐭𝐮𝐫𝐞 𝐭𝐡𝐚𝐭 𝐡𝐨𝐬𝐭𝐬 𝐦𝐮𝐥𝐭𝐢-𝐦𝐢𝐥𝐥𝐢𝐨𝐧-𝐨𝐮𝐧𝐜𝐞 𝐝𝐞𝐩𝐨𝐬𝐢𝐭𝐬 𝐞𝐥𝐬𝐞𝐰𝐡𝐞𝐫𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐓𝐞𝐧𝐧𝐚𝐧𝐭 𝐂𝐫𝐞𝐞𝐤-𝐌𝐭 𝐈𝐬𝐚 𝐢𝐧𝐥𝐢𝐞𝐫.

So what does all this mean?

Internally, the company is cautious, but the scale is writ large. 𝐀 𝟑𝐤𝐦-𝐥𝐨𝐧𝐠 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐨𝐫 𝐰𝐢𝐭𝐡 𝐰𝐢𝐝𝐭𝐡𝐬 𝐨𝐟 𝟐𝟎𝟎𝐦 𝐭𝐨 𝟒𝟎𝟎𝐦, 𝐦𝐨𝐝𝐞𝐥𝐥𝐞𝐝 𝐟𝐫𝐨𝐦 𝐬𝐮𝐫𝐟𝐚𝐜𝐞 𝐭𝐨 𝟑𝟎𝟎𝐦 𝐝𝐞𝐩𝐭𝐡, 𝐬𝐮𝐠𝐠𝐞𝐬𝐭𝐬 𝐚 𝐜𝐨𝐧𝐜𝐞𝐩𝐭𝐮𝐚𝐥 𝐞𝐱𝐩𝐥𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐭𝐚𝐫𝐠𝐞𝐭 𝐨𝐟 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝟏𝟓 𝐚𝐧𝐝 𝟐𝟓 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐭𝐨𝐧𝐧𝐞𝐬 𝐚𝐭 𝐚 𝐠𝐫𝐚𝐝𝐞 𝐨𝐟 𝟏.𝟓 𝐭𝐨 𝟐.𝟓 𝐠/𝐭 𝐠𝐨𝐥𝐝.

That’s a 𝟏.𝟓 𝐭𝐨 𝟑 𝐦𝐢𝐥𝐥𝐢𝐨𝐧-𝐨𝐮𝐧𝐜𝐞 𝐬𝐲𝐬𝐭𝐞𝐦 if everything comes together.

These aren’t pie-in-the-sky figures. They’re derived from the same geophysical signatures that led to the discovery of the nearby 1.8Moz Warrego deposit and the high-grade Golden Forty mine.

Now consider this: a discovery hole of, say, 20 metres at 3 g/t gold from 80 metres depth, perfectly achievable given the geochemical and geophysical data, would instantly transform sentiment.

Peers with comparable hits in the Northern Territory routinely trade at market caps of £20-30M. For FDR, that would imply a share price of 𝟏𝟒-𝟐𝟏𝐩; 𝐚 𝐫𝐞𝐭𝐮𝐫𝐧 𝐨𝐟 𝟓 𝐭𝐨 𝟕 𝐭𝐢𝐦𝐞𝐬 𝐭𝐡𝐞 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐥𝐞𝐯𝐞𝐥.

And that is just the re-rate on the first decent intersection.

A multi-hole campaign confirming a broad zone of mineralisation could attract a mid-tier suitor hungry for Australian ounces in one of the world’s last great underexplored gold frontiers.

And the neighbouring catalyst adds an extra layer of excitement.

𝐈𝐭𝐞𝐜𝐡 𝐌𝐢𝐧𝐞𝐫𝐚𝐥𝐬 (ASX: ITM) is about to commence its own drilling campaign at the Golden Gate prospect, a few hundred metres from FDR’s boundary along the Stafford Gold Trend.

Golden Gate already boasts historical intercepts such as 14m at 9.8 g/t Au, and Itech’s programme is designed to extend that mineralisation down-plunge and test a large induced-polarisation anomaly at depth.

𝐈𝐧 𝐞𝐟𝐟𝐞𝐜𝐭, 𝐈𝐭𝐞𝐜𝐡 𝐢𝐬 𝐝𝐫𝐢𝐥𝐥𝐢𝐧𝐠 𝐭𝐡𝐞 𝐧𝐨𝐫𝐭𝐡𝐞𝐫𝐧 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐯𝐞𝐫𝐲 𝐬𝐚𝐦𝐞 𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐚𝐥 𝐜𝐨𝐫𝐫𝐢𝐝𝐨𝐫 𝐭𝐡𝐚𝐭 𝐅𝐃𝐑 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐩𝐫𝐨𝐛𝐢𝐧𝐠 𝐨𝐧 𝐢𝐭𝐬 𝐨𝐰𝐧 𝐠𝐫𝐨𝐮𝐧𝐝.

.

Here's the full article:

🚨 𝐋𝐀𝐍𝐃𝐄𝐑 𝐖𝐄𝐒𝐓 #FDR #GOLD

I’m standing on the red dirt of the Lander West gold target, 250km northwest of Alice Springs, and the silence is about to be shattered.

𝐅𝐢𝐫𝐬𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐑𝐞𝐬𝐨𝐮𝐫𝐜𝐞𝐬 (AIM: FDR) has just completed its final pre-mobilisation reconnaissance.

Drill-holes are refined, the earthworks contractor is locked in, and the rig from GeoDrill Australia is already working next door on Itech Minerals’ ground.

For the first time, this quiet corner of the Northern Territory’s Stafford Gold Trend is about to be properly tested, and at a market capitalisation of just £4M; 𝐭𝐡𝐞 𝐥𝐞𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐨𝐟𝐟𝐞𝐫 𝐢𝐬 𝐭𝐡𝐞 𝐤𝐢𝐧𝐝 𝐨𝐟 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐩𝐫𝐢𝐯𝐚𝐭𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 𝐝𝐫𝐞𝐚𝐦 𝐚𝐛𝐨𝐮𝐭.

Let’s put that £4M into perspective.

With 139.2 million shares in issue, and a share price of 2.85p, FDR is obscenely undervalued. Yet the company is fully-funded for a maiden reverse-circulation drilling programme that will test a target with the geological hallmarks of a multi-million-ounce gold system.

If even the first-pass drilling delivers a discovery, that £4M valuation could be a footnote in a much bigger story.

Meanwhile, astute investors will have noticed the steady drip of stock being fed onto the tape in recent weeks.

𝐅𝐢𝐫𝐬𝐭 𝐄𝐪𝐮𝐢𝐭𝐲 has been acting for Armstrong Investments, a shareholder that accumulated a meaningful position between November 2025 and March 2026. That holding topped out at 6.25%, but since March, the position has been gradually unwound. Today, it sits at just 3% (~4.2 million shares).

The beauty of the 3% threshold is that it represents the floor for the UK’s major shareholding notification regime. Once a stake dips below that line, no further TR1 disclosures are required.

More importantly though, the evidence suggests the heavy lifting is already done. The stock has been absorbing this supply without falling over; in fact, the shares have been gently rising into the news flow.

The remaining rump is small enough to be cleared in a couple of trading days, and with the overhang now largely behind us, the path is clear for the drilling catalysts to do their work.

But back to the investment case here. FDR isn’t chasing a few grams per tonne of oxide gold. The team is hunting a large, structurally controlled, intrusive-related gold system; the kind of deposit that can underpin a standalone mining operation.

.

Well worth a read.

https://x.com/SerialInvestor8

Oilheadgame, you’re reading this exactly right. 15p is definitely achievable in the medium term. Also, it's worth noting that the LSE share count is wrong. There are only 1,139,402,658 shares in issue. At 2.55p, the company is obscenely undervalued.

So, for those still trying to decipher the RNS, here goes;

This morning, CLBX didn’t just announce a deal, it ripped open a direct line into AstraZeneca’s oncology pipeline. A Master Services Agreement turns CelLBxHealth into a qualified CTC analytics provider for clinical trial samples, using the bankable Parsortix® platform.

The technology risk? Already retired. The MSA may not print cash tomorrow, but it greases the wheels for work orders to start flying across AstraZeneca’s drug development machine. In the liquid-biopsy world, these MSAs are famous for turning into multi-year, high-margin contracts almost overnight.

And the set-up could hardly be tighter. Three players, Conifer Management (29.9%), Dermot Keane (15.46%), and Global Frontier Investments (8.98%), control over half the register. That’s a fortress balance of insider and institutional conviction, leaving a wafer-thin free float that will rocket when the first work order lands.

Now the numbers that should make your pulse race. ANGLE plc, the brains behind Parsortix, converted a similar MSA into a single £1.2 million trial. AstraZeneca’s ambitions in personalised oncology are monstrous, so once the relationship matures, three or six parallel studies a year is a conservative bet.

That’s £5 million–£8 million in annual service revenue at gross margins comfortably north of 50%. Slap a 4 x revenue multiple on that stream, standard for specialist CROs, and you’ve just added an obscene amount of upside.

Next, toss in the existing, growing core business and you’re staring at a fair enterprise value of £55 million–£85 million. On a corrected share count, that spits out a risk-adjusted fair value significantly north of the current share price of 2.55p per share.

But the shrewd investors know this and are buying this up. See Level III.

ATB

£300k total → 1.2m shares @ 25p

Today: final £57.5k (230k shares)

✅ All 4 tranches done.

✅ Auto-conversion wasn’t due until Dec 2026

✅ So why convert early? Possibly sophisticated investor with visibility on incoming catalysts?

ATB

For those unaware, 18hrs ago, Rwanda's Trinity Metals confirmed its plan to list in NY, targeting a blockbuster raise of US$200M to accelerate output at what could become one of the world's largest lithium deposits.

https://www.mining.com/web/rwandas-trinity-metals-targets-200m-us-listing-to-boost-tin-tungsten-output/

👉 https://x.com/SerialInvestor8

On this bright Sunday morning, here's some exciting facts about this incredible company;

https://www.rmb.gov.rw/updates/news-detail/rwandas-critical-minerals-for-the-green-transition

✅ Rwanda supplies over 22% of the world's tantalum and is Africa's largest tungsten producer; a reality that directly amplifies the Aterian story on two clear fronts.

✅ Today's Driver: Aterian's tantalum trading JV with Wogen Resources is already plugged into this high-grade, traceable flow. The model is working: the Rwandan trading arm delivered strong, self-funded gross profit growth in early 2026, proving the asset-light, cash-generating thesis in real time.

✅ Tomorrow's Optionality: With exploration ground like Musasa (100% owned) showing confirmed tungsten potential, Aterian sits on a latent second leg of growth. The company has the local relationships and infrastructure to pivot into tungsten exposure whenever conditions warrant, giving shareholders a free upside call on Africa's #1 tungsten jurisdiction.

🚨In essence, Aterian has secured a profitable, operational foothold in one of the planet's most critical 3Ts supply chains, with a clear path to double down on a second major commodity at its discretion.

Stay put.

.

Howard Stanley Marks, one of the most successful contrarian investors, once opined that: “The best opportunities are often found when the crowd is looking the other way.”

FAIR VALUE (ATERIAN PLC)

✅ Lithosquare licenses (8 licenses, 20% sold for €1.4M) → £6.1M

✅ HCK Project (Rio Tinto spent US$5M proving it up) → £2.0M

✅ Agdas copper-silver project (fully permitted) → £1.0M

✅ Tantalum trading JV with WOGEN (target £1M net profit in 2027) → £12.0M (12x PE, adjusted following Q1 2026 trading update)

✅ Remaining exploration acreage (Rwanda, Botswana, Morocco) circled by Tier-1 operators → £5.0M

✅ Excellent management pedigree (Yale, Harvard, and Witwatersrand Universities) and full BOD alignment (15.21%) and considering an MBO → £...

👉 Total Fair Value → £26.1M (148p per share)

Spodulike, this should be nearer 148p, IMHO.

.

FWIW, this is a great summary of the state of play today.

https://x.com/SerialInvestor8

Base Case Valuation:

Incorporates full year 2026/27 JV projections plus recent exploration advances. 12x P/E on trading net profit.

Total: £28.4M (161p per share)

Bull Case Valuation:

Assumes strong commodity prices (tantalum at all-time highs ~US$225/lb), successful development outcomes, and full delivery of strategic targets. £42.9M (243p/share)

The Bottom Line:

The market is valuing Aterian at £5.13 million – less than the standalone value of its trading JV alone under any reasonable multiple.

The Wogen JV has been active for one month. That single month’s gross profit already exceeded the entire previous quarterly run rate.

Annualised, the JV is on track for nearly £800,000 net profit in 2026. The company’s 2027 target of £1 million net profit looks not just achievable, but potentially conservative.

The assets are real. The billion-dollar partner is a Top-Five global. And the valuation gap is extraordinary.

.

FWIW, I’ve gone back and crunched the numbers relating to Aterian’s Q1 2026 trading update.

Gross profit from Rwandan operations reached approximately £237,000 (US$306,000) — more than double the £112,000 (US$145,000) delivered in Q4 2025.

More importantly, the Wogen JV went operational on 02 March 2026. That means the Q1 figure includes just ONE MONTH of JV-enhanced trading. January and February still ran on the older, less efficient model.

Strip out those two months, and the math becomes interesting:

January–February (old model): ~£112,000 gross profit total (based on Q4 run rate)

March (first month of Wogen JV): ~£125,000 gross profit – more than double the previous monthly rate of £56,000

In its very first month, the JV is already firing at an annualised gross profit run rate of £1.5 million!

We then apply a conservative 12x price-to-earnings multiple to the trading JV’s net profit. Below are three valuation scenarios – each grounded solely in official RNS’ and third party commitments. No speculation. Just fact.

The Starting Truth:

Aterian has 17,684,000 ordinary shares in issue. At 29p per share, the entire company – all exploration assets, trading operations, and partnerships – is valued by the market at a mere £5.13 million.

Let’s test that against reality.

Projected 2026 Trading Performance (JV active March–December = 10 months):

a) 10 months at March run rate: £1.25 million gross profit

b) Add January–February: £0.11 million

c) Total 2026 estimated gross profit: £1.36M

The trading business carries minimal operating expenses (traceability, logistics, limited overheads). Applying a conservative 60% net margin (the JV improves working capital and reduces funding costs) gives 2026 estimated net profit of ~£820,000.

Projected 2027 Trading Performance:

The company has explicitly targeted £1 million net profit from trading in 2027. With a full year of JV operation, and a move to a larger processing facility, I see £1.0–1.2 million as readily achievable. The Base Case uses the company’s own £1.0 million target.

Conservative Sum of the Parts (SOTP) Valuation:

a) Exploration Licences (Lithosquare) → Strategic partner spending €1.4M for 20% → 100% worth €7M. In pound sterling, £6.1M

b) HCK Project (Rio Tinto validation) → Mining giant spent US$5M proving it up. Sunk cost has real value. In pound sterling, £2.0M

c) Moroccan Copper Silver Project (Agdas) → Environmental approval secured, materially de risked. Conservative placeholder of £1.0M

d) Tantalum Trading JV with Wogen → Targeting £1M net profit in 2027. At 12x P/E (justified by Wogen’s pedigree) we get £12.0M

e) Remaining Exploration Portfolio → Rwanda, Botswana, Morocco acreage. Nominal but reasonable value of £5.0M

TOTAL SOTP VALUE → £26.1M (148p/share)

That’s 5x upside to reach the conservative sum of the parts valuation.

.

Tedc, Break100, Crumbs et al, I agree; an absolutely stunning interview!

But more importantly, and following today’s explosive interview (45mins in…), investors are left with a single, clear conclusion: the market has fundamentally mispriced this company, and those closest to the assets have had enough.

Chiefly, every major shareholder in the company, and the entire BoD, has sold not a single share!

That level of insider retention, in a sub‑£5M market cap company, is rare. What is rarer still is the chairman publicly stating that a MANAGEMENT BUYOUT IS NO LONGER A THEORETICAL CONCEPT.

Bray made clear that, if the market persists in valuing the company at current levels, there is no reason an MBO would be out of question. That statement, alone, should command every investor's attention.

When the people who know the assets best are actively discussing taking the company private because the market has, in effect, ‘lost it’, then it pays to sit up and pay attention.

And better still, we now have an incoming catalyst in the form of a trading update on Tuesday (07/04/2026) – confirmed by the Chairman himself. The aggressive re-rate implications of a bullish update cannot be understated with a super tight free float.

BOTTOM LINE:

Whether management ultimately executes a buyout or the market re‑rates first, the asymmetry is now impossible to ignore.

Well done to all those who managed to get in on Thursday, and a Happy Easter to all the LONGS!

.

For those unaware, 23hrs ago, Aterian’s Executive Chairman, Charles Bray, did something that every serious investor should recognise as a clear and deliberate signal. He posted the following:

https://www.linkedin.com/in/charles-g-bray-a45979/?skipRedirect=true

The X post, as most of you are aware, concluded that Aterian is worth 136p per share (Fair Value); a 6x upside from the previous price of 23p.

Thus, when an Executive Chairman amplifies a third-party valuation that is nearly six times higher than the share price, he is endorsing the numbers and telling the market that his company is dramatically undervalued.

Make no mistake, this is as close to a formal undervaluation statement as you get without a regulatory announcement.

But more importantly, Bray would not have reposted this if he did not believe it. He has a fiduciary duty to shareholders, and by putting his name behind these numbers, he is effectively telling the market that 136p is a reasonable fair value and that the current 27.50p share price is absurd.

Hold the line.

.

Https://x.com/SerialInvestor8/status/2039538557782503492

ATB

Another significant value catalyst delivered in today's RNS.

Let's go!

.

BOTTOM LINE:

For private investors on the side lines, the message is unmistakable. Aterian has a funded, scaled trading platform with a billion-dollar partner, targeting profitability in 2026. It has a fully owned exploration portfolio that includes a project Rio Tinto spent millions proving. It has AI partners spending millions to earn into its licenses. It has a management team that has executed partnerships with the world's best. And the entire package trades at £4m?

Bray's bewilderment is your opportunity.

One Word: Multibagger!

.

Then there is HCK, the Rwandan project where Rio Tinto spent US$4.7 million proving mineralisation before walking away because it wasn't Tier-1 scale. For Aterian, it is a company-maker. Bray walked investors through the numbers:

"From our preliminary analysis, it's approximately 35% Tantalum and approximately 40% Niobium, and that's virtually the entire hill that you can see."

The tantalum price has more than trebled since Rio walked. Bray confirms:

"Last year this time, we could have worked on developing HCK and it still would have been profitable. So we're in a much, much better situation. The company is now in discussions with partners to take HCK into development by the end of this year.”

The competitive landscape is equally telling. When asked who else provides fully traceable, conflict-free tantalum at scale, Bray was candid:

"If you read the reports by the various NGOs... nobody, just us." He acknowledged Traxys as a billion-dollar competitor, but concluded:

"That's our only competition. Aterian IS ONE, OF TWO PLAYERS IN THE WORLD, offering what the market increasingly demands: certified, ethical, fully traceable critical minerals.”

The demand drivers are accelerating. Bray notes that:

“Tantalum is not a niche curiosity; it is the hidden backbone of the AI revolution, and Aterian has a front-row seat.”

The exploration portfolio is also advancing. The EIA approval for Agdz in Morocco has been secured, a milestone Bray describes as "not easy to come by." It de-risks the project and accelerates development.

And Lithosquare, the AI exploration partner, has completed its targeting. Bray reveals:

"They matched off with what we had prioritised, not necessarily in the same order. The work they did was actually quite remarkable. They did the equivalent of what it would take us probably 20 geologists to do over the past three to four months. The announcement of their expenditure focus is imminent.”

Which brings us back to the valuation. Bray's closing comments are the most damning indictment of the market's inefficiency.

"Rio Tinto spending US$5 million on HCK1 alone gives you some indication of what Eastinco or the Rwandan business is worth. That's not counting the trading. Lithosquare spending 1.4M Euros across eight different licenses gives you an indication of what those eight licenses are worth. And that's for 20% of those licenses. I think it just boggles the mind."

Then the punchline:

"I no longer believe in the efficient market hypothesis."

.